Picard Medical, Inc. (PMI)
NYSEAMERICAN: PMI · Real-Time Price · USD
3.150
-0.130 (-3.96%)
Oct 30, 2025, 9:58 AM EDT - Market open
Company Description
Picard Medical, Inc., through its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products.
The company offers SynCardia TAH, an artificial heart for patients that is designed to function as a failed human heart in patients suffering from advanced heart failure.
The company operates in the USA, Europe, and internationally. The company was incorporated in 2021 and is based in Tucson, Arizona.
Picard Medical, Inc. is a subsidiary of Hunniwell Picard I, Llc.
Picard Medical, Inc.
| Country | United States |
| Founded | 1981 |
| IPO Date | Aug 29, 2025 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 75 |
| CEO | Patrick Schnegelsberg |
Contact Details
Address: 1992 E Silverlake Road Tucson, Arizona 85713 United States | |
| Phone | 520 545 1234 |
| Website | syncardia.com |
Stock Details
| Ticker Symbol | PMI |
| Exchange | NYSEAMERICAN |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $4.00 |
| CIK Code | 0002030617 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Patrick Schnegelsberg | Chief Executive Officer |
| Bernard Skaggs | Chief Financial Officer |
| Matthew Schuster | Chief Operating Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 27, 2025 | 8-K | Current Report |
| Oct 14, 2025 | 8-K | Current Report |
| Sep 29, 2025 | DEF 14A | Other definitive proxy statements |
| Sep 18, 2025 | PRE 14A | Other preliminary proxy statements |
| Sep 12, 2025 | 10-Q | Quarterly Report |
| Sep 10, 2025 | 8-K | Current Report |
| Sep 4, 2025 | 8-K | Current Report |
| Sep 2, 2025 | 424B4 | Prospectus |
| Aug 28, 2025 | CERT | Certification by an exchange approving securities for listing |
| Aug 12, 2025 | EFFECT | Notice of Effectiveness |